Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2022 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2045 Perioperative Outcomes of Surgery for Pancreatic Neuroendocrine Neoplasms in Germany

Introduction: The incidence of pancreatic neuroendocrine neoplasms(pNEN) is increasing and the perioperative outcomes of specialized centers are favourable.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Mintziras I, Werner J, Keck T, Hommann M, Germer C,

Keywords: pancreatic neuroendocrine neoplasms, surgical resection, StuDoQ|pancreas registry,

#2044 Are Current ENETS Guidelines for Surgery of Small (< 2cm) Pancreatic Neuroendocrine Neoplasms Implemented in German Surgical Community?

Introduction: According to ENETS guidelines small(<2cm) pNEN should be operated laparoscopically with parenchyma-sparing resection without formal lymphadenectomy.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Mintziras I, Werner J, Keck T, Hommann M, Germer C,

Keywords: small (<2cm) pancreatic neuroendocrine tumors, surgical resection, StuDoQ|pancreas registry,

#1596 Triple Tracer Imaging Approach for the Non-Invasive Assessment of Chemokine Receptor 4 Expression in Gastroenteropancreatic Neuroendocrine Tumors

Introduction: The theranostic twins [68Ga]Pentixafor and [177Lu]Pentixather for chemokine-directed endoradiotherapy (ERT) were recently developed.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Werner R

Authors: Werner R, Weich A, Higuchi T, Schmid J, Schirbel A,

Keywords: Neuroendocrine tumor, [68Ga]Pentixafor, CXCR4, PRRT, PET/CT,

#1588 Response Prediction for Vandetanib Treatment in Recurrent Medullary Thyroid Carcinoma using F18-FDG PET

Introduction: Given its neuroendocrine origin, the prognosis of medullary thyroid carcinoma (MTC) remained poor in common chemotherapeutic approaches. However, the encouraging results of tyrosine kinase inhibitors (TKI) such as vandetanib emphasize the high demand for selecting appropriate candidates.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Werner R

Authors: Werner R, Schmid J, Higuchi T, Buck A, Aulmann C,

Keywords: FDG, MTC,

#1545 In Vivo Expression of Survivin and XIAP in Medullary Thyroid Carcimoma

Introduction: Medullary thyroid carcinoma (MTC) accounts for approximately 5 % of all thyroid malignancies. Although surgery remains the first line therapy with curative intention, for advanced MTC current chemotherapeutic regimes do not provide promising results. Consequently, the identification of biologically relevant biomarkers that are associated with MTC progression may provide novel therapeutic targets.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Werner T

Authors: Werner T, Riemer J, Dizdar L, Wolf A, Cupisti K,

Keywords: MTC, IAP, survivin, XIAP,

Abstract Submissions in 2023

Abstract submissions for 2023 will open in September 2022!

 

The 20th Annual ENETS Conference in 2023 will provide the principal platform for NET researchers around the world to present their latest findings. ENETS will select the best abstracts submitted in both clinical and basic science and present these in sessions within the framework of its scientific programme.

 

Participants of the ENETS Conferences in 2022 can now access the abstract booklet, e-posters and videos, the poster carousel, and more via My ENETS.

Membership matters

Multidisciplinary is our credo. We welcome all NET-related disciplines and professionals! Learn more about the benefits of becoming an ENETS member.